Tectonic Therapeutic (TECX) Accumulated Depreciation (2017 - 2025)
Tectonic Therapeutic's (TECX) quarterly Accumulated Depreciation came in at $3.4 million in Q4 2025, up 24.12% year-on-year from $2.7 million in Q4 2024, and up 7.14% on a QoQ basis from $3.2 million in Q3 2025.
Tectonic Therapeutic (TECX) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Accumulated Depreciation data on file, last reported at $3.4 million in Q4 2025.
- On a quarterly basis, Accumulated Depreciation rose 24.12% year-over-year to $3.4 million in Q4 2025; TTM through Dec 2025 was $3.4 million, a 24.12% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 24.12% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $3.4 million, up from $3.2 million in the prior quarter.
- Over the last five years, Accumulated Depreciation for TECX reached as high as $4.6 million in Q2 2022 and fell as low as $1.9 million in Q4 2023.
- Historically, Accumulated Depreciation has averaged $3.4 million across 5 years, with a median of $3.4 million in 2021.
- Across the five-year window, Accumulated Depreciation jumped 78.77% in 2021 and sank 51.21% in 2023, its largest moves.
- Year by year, Accumulated Depreciation stood at $3.8 million in 2021, then retreated by 0.42% to $3.8 million in 2022, then slumped by 51.21% to $1.9 million in 2023, then surged by 47.9% to $2.7 million in 2024, then gained by 24.12% to $3.4 million in 2025.
- Per Business Quant data, the three most recent Accumulated Depreciation figures were $3.4 million in Q4 2025, $3.2 million in Q3 2025, and $3.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.41 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.13 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 4.42 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 3.46 Mn |
| Jun 30, 2022 | 4.57 Mn |
| Mar 31, 2022 | 4.22 Mn |
| Dec 31, 2021 | 3.82 Mn |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | 3.01 Mn |
| Mar 31, 2021 | 2.71 Mn |
| Dec 31, 2020 | 2.42 Mn |
| Sep 30, 2020 | 2.13 Mn |